Phase 1 Study of 3D229 in Healthy Subjects

NCT04941313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subject

Interventions

DRUG: 3D229
OTHER: Placebo

Sponsor

3D Medicines